Inside Drug Pricing

Launch Prices Rising Faster Than Prices For Existing Drugs

By John Wilkerson / January 7, 2022 at 3:07 PM

Launch prices are rising faster than prices for existing drugs, according to research by the drug price watchdog 46Brooklyn, and that’s bad news for Democrats, who recently changed their drug pricing bill to prevent Medicare from negotiating launch prices.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.

FEATURES

NEWSLETTERS

ABOUT US

Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.

SITE LICENSES

Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.

STAY CONNECTED

Inside Drug Pricing

Launch Prices Rising Faster Than Prices For Existing Drugs

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.